Sangrix Inc. SGRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 108.73% | 108.73% | -47.01% | -47.01% | -69.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -578.20% | -578.20% | 358.18% | 358.18% | 241.96% |
| Operating Income | 595.56% | 595.56% | -358.18% | -358.18% | -236.99% |
| Income Before Tax | -50.89% | -50.89% | -551.07% | -551.07% | 67.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -50.89% | -50.89% | -551.07% | -551.07% | 67.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 220.00% | 220.00% | -314.49% | -314.49% | -104.11% |
| Net Income | -48.63% | -48.63% | -555.28% | -555.28% | 64.40% |
| EBIT | 595.56% | 595.56% | -358.18% | -358.18% | -236.99% |
| EBITDA | -- | -- | -- | -- | -180.11% |
| EPS Basic | 53.33% | 53.33% | 35.13% | 35.13% | 93.51% |
| Normalized Basic EPS | 20.33% | 20.33% | 60.64% | 60.64% | 72.64% |
| EPS Diluted | 53.33% | 53.33% | 35.13% | 35.13% | 93.51% |
| Normalized Diluted EPS | 20.33% | 20.33% | 60.64% | 60.64% | 72.64% |
| Average Basic Shares Outstanding | 218.55% | 218.55% | 910.26% | 910.26% | 448.48% |
| Average Diluted Shares Outstanding | 218.55% | 218.55% | 910.26% | 910.26% | 448.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |